➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Merck
Boehringer Ingelheim
Express Scripts
McKinsey

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

Urokinase - Biologic Drug Details


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for urokinase

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Hellenic Institute for the Study of SepsisPhase 2
Denver Health and Hospital AuthorityPhase 2
Genentech, Inc., University of Colorado Denver, National Jewish, Beth Israel Deaconess Medical Center, and Long Island Jewish HospitalPhase 2

See all urokinase clinical trials

Recent Litigation for urokinase

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Vytacera Bio, LLC v. CytomX Therapeutics, Inc.2020-03-04
Genentech, Inc. v. Pfizer Inc.2019-04-05
Genentech, Inc. v. Samsung Bioepis Co., Ltd.2018-09-04

See all urokinase litigation

PTAB Litigation
PetitionerDate
2016-11-22
2013-12-02
2012-09-25

See all urokinase litigation

Patent Text Search: US Patents for urokinase

These patents were identified by searching patent claims

Supplementary Protection Certificates for urokinase

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
358 Luxembourg   Start Trial PRODUCT NAME: LIPEGFILGRASTIM
2014902227610 Italy   Start Trial PRODUCT NAME: LIPEGFILGRASTIM(LOQUEX); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/13/856/001-002, 20130725
/2013 Austria   Start Trial PRODUCT NAME: OCRIPLASMIN; REGISTRATION NO/DATE: EU/1/13/819/001 20130313
C0007 France   Start Trial PRODUCT NAME: LIPEGFILGRASTIM; REGISTRATION NO/DATE: EU/1/13/856 20130725
01730054 Spain   Start Trial PRODUCT NAME: NONACOG BETA PEGOL; NATIONAL AUTHORISATION NUMBER: EU/1/17/1193; DATE OF AUTHORISATION: 20170602; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/17/1193; DATE OF FIRST AUTHORISATION IN EEA: 20170602
0851925/01 Switzerland   Start Trial FORMER REPRESENTANTIVE: BOVARD AG PATENTANWAELTE, CH
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Medtronic
AstraZeneca
McKesson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.